Panel Discussion: Surveying Current Investor Sentiment in Gene Therapy to Strengthen Your Funding Strategy

9:00 am - Thursday 26th March 2026

  • Understanding what drives interest and what’s driving hesitation across the field
  • Discussing the role of policy, regulation, and public trust in shaping long-term investment
  • Reviewing the various sources of funding that exist for companies beyond VCs

Speakers:

Chief Executive Officer & Board Director
Adolore BioTherapeutics
Vice President
Agent Capital
Chief Executive Officer
Vinta Bio
Vice President - Research & Partner
CureDuchenne